Pricing Log in Create free account

Eocene Ltd. (EOCN) vs NeuroSense Therapeutics Ltd. (NRSN)

Eocene Ltd. and NeuroSense Therapeutics Ltd. are both Biotechnology companies. Eocene Ltd. and NeuroSense Therapeutics Ltd. are of similar size ($2.6M and $2.6M). Across the 8 metrics below, Eocene Ltd. leads on 4 and NeuroSense Therapeutics Ltd. on 4.

Valuation

Metric EOCN NRSN Biotechnology median
P/E n/m n/m 10.60
P/S 1.28 n/m 9.40
P/B 0.20 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.63 n/m 0.66
EV/Sales (3.06) n/m 9.02
Earnings yield (518.42%) (832.79%) (32.88%)
Free cash flow yield (327.63%) (909.43%) (23.13%)

Profitability

Metric EOCN NRSN Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (68.21%) 0.00% (51.96%)
Return on assets (55.03%) 0.00% (46.06%)
Return on invested capital (163.19%) 0.00% 0.00%

Growth

Metric EOCN NRSN Biotechnology median
Revenue growth (TTM) 87.83% — 6.76%
EPS growth (last fiscal year) 70.42% 18.52% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EOCN NRSN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.16 0.28 4.97
Net debt to EBITDA 1.31 0.01 1.01

Dividend

Metric EOCN NRSN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric EOCN NRSN Biotechnology median
Market cap 2.56m 2.64m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack